Answer first: Before printing a focus claim, write down the exact consumer takeaway and identify human evidence that fits the sold pouch. Check ingredient identity, dose per serving, combination, oral delivery route, study population and measured outcome. Keep negative or conflicting findings in the file. FTC guidance requires health-product advertising to be truthful, not misleading and supported by competent and reliable scientific evidence. U.S. dietary-supplement label rules, if that classification lawfully applies, are a separate review.
What belongs in a claim substantiation dossier?
Start with a claim register covering the can, website, retailer page, social post and sales sheet. Record the exact words, visuals and implied message, then attach the evidence and a brief explanation of why it applies to this formulation. A claim about faster onset, absorption or superior performance needs evidence for that comparative outcome; it is not established by a general ingredient paper. Assign an owner and review date so an old study is not copied into a new SKU’s file without checking dose and composition.
One row per proposed claim
- Exact claim and where consumers will see it
- Reasonable express and implied takeaway
- Ingredient, dose, route and population match
- Human study design and outcome
- Conflicting evidence and final approved wording
Why does ingredient research not automatically prove a pouch claim?
A study may use a capsule, beverage or higher dose than the proposed oral pouch. It may test a single substance while the product contains a blend, or measure a task that differs from the advertisement’s promise. The FTC specifically asks marketers to compare the study product’s dosage, formulation, administration route, outcomes and population with the advertised product. A plausible mechanism or an animal result can inform research planning, but it does not by itself substantiate a consumer health benefit.
How should ‘supports focus’ be reviewed?
Even moderate wording is an objective health-related claim if consumers take it as a promise of benefit. Identify the precise attention or performance outcome and the intended adult user. Review well-controlled human evidence in the context of the full body of research, including null findings. Do not convert a brief alertness result into a claim about memory, ADHD, anxiety treatment or IQ. If a formulation uses caffeine, the dose and warnings must also be assessed for the intended market and users.
What U.S. label boundary applies?
First obtain a classification review for the exact product and route of use. If it is lawfully marketed as a dietary supplement in the United States, structure/function and related labeling claims have specific conditions, including substantiation, the required disclaimer and notification to FDA within 30 days after first marketing with the claim. A notification is not FDA preapproval. Disease-treatment claims can change the regulatory analysis. The FTC’s advertising standard applies separately to marketing content, so a compliant label format does not rescue unsupported advertising.
When must the dossier be reopened?
Reopen it after any dose, ingredient supplier, extract specification, pouch format, intended user, market, or wording change. Also review it when new human studies materially alter the balance of evidence. A brand can preserve a narrow, supported statement while deleting a broader unsupported one. Document the decision and version so distributors receive the same approved copy as the brand website.
Frequently asked questions
Does an ingredient study prove the finished pouch works?
Not automatically. Compare the studied dose, formulation, route, population and outcome with the sold product and claim.
Is ‘supports focus’ exempt from evidence requirements?
No. Objective health-related claims still need appropriate substantiation.
Does FDA notification approve a U.S. dietary-supplement claim?
No. Where notification is required, it is not premarket approval of the claim.
Can an in-vitro study support a consumer benefit alone?
Generally no. Mechanistic work can provide context, but the FTC generally expects relevant human evidence for health benefits.
Authoritative references
- FTC, Health Products Compliance Guidance
- FDA, Structure/Function and Related Claims Notifications
- NIH ODS, Product Integrity Guidance
Related buyer resources
Reviewed October 29, 2026. This buyer guide is educational; confirm product classification, methods and claims for the exact formula and destination market.
